Daiwa Securities Group Inc. Corbus Pharmaceuticals Holdings, Inc. Transaction History
Daiwa Securities Group Inc.
- $22.4 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding CRBP
# of Institutions
4Shares Held
38.7KCall Options Held
0Put Options Held
0-
Kingsbury Capital Investment Advisors LLC Evanston, IL33.7KShares$301,9520.01% of portfolio
-
Exane Derivatives2.65KShares$23,7440.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.31KShares$20,7150.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Corbus Pharmaceuticals Holdings, Inc.
- Ticker CRBP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 125,268,000
- Market Cap $1.12B
- Description
- Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...